Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 12 - 75 |
| Updated: | 10/6/2018 |
| Start Date: | June 20, 2018 |
| End Date: | July 2019 |
| Contact: | Kathleen Sherman |
| Email: | Kai.Sherman@nyumc.org |
| Phone: | 929-455-5125 |
Participants with neurological disorders will be recruited to complete sessions of virtual
reality (VR) immersion. VR has been shown to have therapeutic benefit in certain patient
populations and requires further clinical study to determine the extent to which VR can be
used to rehabilitate and reduce symptom burden. This study seeks to pilot newly developed VR
methods and collect preliminary data in order to support research grants and inform larger
clinical trials. Additionally, this proposed study will explore the tolerability and
preliminary efficacy of Virtual Reality (VR), specifically to determine whether VR can
acutely reduce the severity of symptom burden caused by neurological disorders.
reality (VR) immersion. VR has been shown to have therapeutic benefit in certain patient
populations and requires further clinical study to determine the extent to which VR can be
used to rehabilitate and reduce symptom burden. This study seeks to pilot newly developed VR
methods and collect preliminary data in order to support research grants and inform larger
clinical trials. Additionally, this proposed study will explore the tolerability and
preliminary efficacy of Virtual Reality (VR), specifically to determine whether VR can
acutely reduce the severity of symptom burden caused by neurological disorders.
Inclusion Criteria:
- Has been diagnosed by a clinician as having a neurological disorder
- Able to commit to the designated period of testing
- Able to understand the informed consent process and provide consent to participate in
the study
- Capacity to complete study procedures as determined by screening personnel
Exclusion Criteria:
- Visual, auditory, and motor deficits that would prevent full ability to understand
study
- Visual, auditory, and motor deficits that would prevent full ability to operate VR
equipment
- Uncontrolled epilepsy
- Currently pregnant or plans to become pregnant while taking part in study
- Current diagnosis of vertigo
- Uncontrolled mood disorders
- History of Psychosis or Schizophrenia
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Leigh Charvet, MD
Phone: 929-455-5125
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
